ORINF OTC
Orion Oyj
1W: +0.0%
1M: +11.2%
3M: +11.2%
YTD: +13.2%
1Y: +14.4%
3Y: +157.3%
5Y: +162.2%
$92.05
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$13.0B
52W Range78.95-92.05
Volume100
Avg Volume87
Beta0.31
Dividend$2.00
Analyst Ratings
No analyst coverage
Company Info
CEOAino Anna Liisa Hurme
Employees4,029
SectorHealthcare
IndustryDrug Manufacturers - General
IPO Date2013-05-28
Websiteorionpharma.com
Orionintie 1A
Espoo, UU 02200
FI
Espoo, UU 02200
FI
358 10 4261
About Orion Oyj
Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. It specializes in central nervous system disorders, oncology, and respiratory diseases. The firm's customers are specialist and general practitioners, veterinarians, pharmacies, hospitals, healthcare centers, clinics, and laboratories. The company was founded by Onni Turpeinen, Eemil Tuurala and Wikki Valkama on September 21, 1917 and is headquartered in Espoo, Finland.
Recent Insider Trades
No insider trades found